Acer Therapeutics Inc. Employee Directory
Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees
Acer Therapeutics is a small pharmaceutical company based in Newton, Massachusetts, focused on acquiring, developing and commercializing therapies for serious rare and life-threatening diseases with significant unmet medical needs. Its pipeline includes ACER-001 for inborn errors of metabolism such as urea cycle disorders and Maple Syrup Urine Disease; emetine hydrochloride as a host-directed therapy for infectious diseases (initially COVID-19); EDSIVO (celiprolol) for vascular Ehlers-Danlos syndrome in patients with COL3A1 mutations; and osanetant for induced vasomotor symptoms. Acer characterizes its candidates as bearing comparatively de-risked profiles, supported by favorable safety data, mechanistic differentiation, or accelerated development pathways under FDA processes.